The initial PMI of Markit manufacturing industry in the United States in May was 57.5, which is expected to be 57.5, compared with the previous value of 59.2.
The initial PMI of Markit manufacturing industry in the United States in May was 57.5, which is expected to be 57.5, compared with the previous value of 59.2.
This text is a result of machine translation.
Briefing Yesterday 08:55 PM
· Healthcare
Wuzhou medical won lots: 34000 in total
In-depth
Briefing Yesterday 08:04 PM
· Healthcare
LME three-month tin price rose by more than 10% to US $27100 / ton.
Briefing Yesterday 07:54 PM
· Healthcare
Dongfang Shenghong: the subsidiary plans to invest 3.94 billion yuan in the construction of 2.4 million tons / year purified terephthalic acid (PTA) phase III Project
Apr 28, 2022 08:00 PM
Apr 18, 2022 06:30 PM
Apr 22, 2021 03:11 PM
Dec 19, 2020 07:42 AM
Briefing Updated 4 hours ago
· Healthcare
Aibo biology: cooperate with Jiahe biology to jointly develop tumor mRNA drugs
Briefing Updated 3 hours ago
· Healthcare
Yi Ming ang Ke delivers a statement to the main board of the Hong Kong stock exchange to develop a new generation of tumor immunotherapy
In-depth
Healthcare
BeiGene: a Vast Opportunity Lies Ahead – But We Remain Cautious
BeiGene, a leader in China's novel pharmaceutical industry, recently received approval in Kuwait, Bahrain, and Qatar for its medication BRUKINSA (zanubrutinib). Previous contracts with major biopharma have produced substantial licensing income, but they did not lessen BeiGene's financial burden.
Jun 24, 2022 12:13 PM
Briefing Updated 3 hours ago
· Healthcare
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
Briefing Updated 3 hours ago
· Healthcare
And platinum medicine b7h4x4-1bb bispecific antibody were approved by FDA for new drug research
Briefing Updated 3 hours ago
· Healthcare
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
Industrials, Technology
ChangingBio Completes a CNY 140 million Series A Round of Funding
ChangingBio (Chinese: 昌进生物) completed a CNY 140 million Series A round of funding. Bits x Bites led this funding round, followed by Eight Roads Ventures, Sherpa Venture Capital, GL Ventures, Grand Flight Investment, and Country Garden Venture Capital.
Jun 23, 2022 04:05 PM
Healthcare
RNA Biotech Therorna Bags Over CNY 280 Mn in Series A Financing Round
Therorna, specialized in the development of cutting-edge circular RNA technology-based vaccines and therapies, will accelerate the development of a new broad-spectrum COVID-19 vaccine and other product pipelines with the fresh proceeds.
Jun 23, 2022 03:45 PM
Briefing Updated 3 hours ago
· Healthcare
It is expected to achieve functional cure of chronic hepatitis B! GSK antisense therapy phase IIB positive clinical results
Briefing Updated 11 hours ago
· Healthcare
The attorneys general of 22 US States issued a joint statement promising to support and expand abortion care services
Briefing Updated 1 hour ago
· Industrials
National Development and Reform Commission: focus on three areas and actively expand effective investment
See more
Read next
In-depth
In-depth
In-depth
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.